The m2 muscarinic acetylcholine receptor subtype mediates the regulation of the heartbeat by the parasympathetic nervous system and is of interest as a possible target for antiarrhythmia drugs. The long-term objective of this proposal is to understand the molecular mechanism of m2 receptor signal transduction in as much detail as possible. The recombinant m2 receptor expressed in Chinese Hamster ovary cells provides a useful system to accomplish this goal. Site-directed mutagenesis is combined with ligand binding and kinetic approaches to examine structure/function relationships for receptor amino acids and to develop quantitative mechanisms describing the manner in which the receptor binds ligands and couples to stimulation of phosphatidylinositol metabolism and inhibition of cAMP formation. The recombinant protein can also be purified from overexpressing cell lines in sufficient quantities for biophysical studies such as far ultraviolet circular dichroism and Fourier transform infrared spectroscopy to analyze receptor structure. These studies should contribute to our understanding of m2 receptor structure and the mechanism of m2 muscarinic receptor signal transduction from a quantitative perspective and may result in the rational design of more effective antiarrhythmic agents.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL023632-19
Application #
2735058
Study Section
Special Emphasis Panel (ZRG4-TOX-1 (01))
Project Start
1980-12-01
Project End
2000-06-30
Budget Start
1998-07-01
Budget End
2000-06-30
Support Year
19
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Oregon State University
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
053599908
City
Corvallis
State
OR
Country
United States
Zip Code
97339
Mosser, Valerie A; Amana, Ian J; Schimerlik, Michael I (2002) Kinetic analysis of M2 muscarinic receptor activation of Gi in Sf9 insect cell membranes. J Biol Chem 277:922-31
Vogel, W K; Peterson, G L; Broderick, D J et al. (1999) Double mutant cycle analysis of aspartate 69, 97, and 103 to asparagine mutants in the m2 muscarinic acetylcholine receptor. Arch Biochem Biophys 361:283-94
Vogel, W K; Sheehan, D M; Schimerlik, M I (1997) Site-directed mutagenesis on the m2 muscarinic acetylcholine receptor: the significance of Tyr403 in the binding of agonists and functional coupling. Mol Pharmacol 52:1087-94
Bulseco, D A; Schimerlik, M I (1996) Single amino acid substitutions in the pm2 muscarinic receptor alter receptor/G protein coupling without changing physiological responses. Mol Pharmacol 49:132-41
Vogel, W K; Mosser, V A; Bulseco, D A et al. (1995) Porcine m2 muscarinic acetylcholine receptor-effector coupling in Chinese hamster ovary cells. J Biol Chem 270:15485-93
Hirschberg, B T; Mosser, V A; Peterson, G L et al. (1995) Kinetic and biophysical analysis of the m2 muscarinic receptor. Life Sci 56:907-13
Peterson, G L; Toumadje, A; Johnson Jr, W C et al. (1995) Purification of recombinant porcine m2 muscarinic acetylcholine receptor from Chinese hamster ovary cells. Circular dichroism spectra and ligand binding properties. J Biol Chem 270:17808-14
Huang, S C; Fortune, K P; Wank, S A et al. (1994) Multiple affinity states of different cholecystokinin receptors. J Biol Chem 269:26121-6
Tota, M R; Schimerlik, M I (1990) Partial agonist effects on the interaction between the atrial muscarinic receptor and the inhibitory guanine nucleotide-binding protein in a reconstituted system. Mol Pharmacol 37:996-1004
Tota, M R; Xia, Z Q; Storm, D R et al. (1990) Reconstitution of muscarinic receptor-mediated inhibition of adenylyl cyclase. Mol Pharmacol 37:950-7

Showing the most recent 10 out of 20 publications